Fibromyalgia may worsen opioid addiction

Chronic pain associated with the condition leads some to increase use of opioids

5:00 AM

Author | Eileen Scahill

woman holding head in sweat clothes sitting on couch yellow
Getty Images

Evidence shows that fibromyalgia, and the chronic pain associated with it, could worsen an opioid use disorder. Researchers at University of Michigan and the Ohio State University and report their findings in PAIN, the official journal of the International Association for the Study of Pain.

Scientists have long suspected a connection between opioid use disorder and chronic pain. Many people first use opioids to treat pain. Chronic pain has been tied to worsening of opioid use disorder and even relapse among those in recovery from opioid addiction. However, researchers didn’t know if all pain has the same effect on this disorder, or if certain pain diagnoses might have a much larger impact. Different impacts might lead to more targeted treatments for people with pain and opioid use disorder. 

We’ve always wondered if people with chronic pain who became addicted to opioids might require a different approach than individuals who become addicted that do not have pain,” said senior author Daniel J. Clauw, M.D., director of the Chronic Pain and Fatigue Research Center at the University of Michigan.

Symptoms of fibromyalgia include widespread body pain, extreme tiredness and difficulty thinking and sleeping. This condition is thought to involve unusually strong pain signals in the brain. 

“Many of the brain pathways and chemicals believed to be involved in fibromyalgia are also involved in opioid addiction. This overlap made us suspect fibromyalgia might worsen opioid use disorder. It’s sort of a double hit hypothesis,” said O. Trent Hall, M.D., lead author and an addiction medicine physician in Ohio State’s Department of Psychiatry and Behavioral Health.

The research team surveyed 125 people living with pain and this disorder, 39 (31%) of whom met criteria for fibromyalgia. Although all participants had pain and used opioids, those with fibromyalgia were much more likely to say pain had worsened their addiction. 

Specifically, those with fibromyalgia more often agreed that pain caused them to continue and increase their opioid use, and that they put off seeking help out of fear their pain would be unbearable if they stopped using opioids. 

“These are serious findings. Worries about pain may cause people with fibromyalgia and OUD to delay getting addiction treatment. In our current overdose crisis, every day a person puts off OUD treatment might be the last day of their life,” said Julie Teater, M.D., study co-author and medical director of addiction medicine at Ohio State Wexner Medical Center.

Researchers also found fibromyalgia was associated with greater odds of fearing that pain might cause relapse in the future. 

“There are ways we can help people living with fibromyalgia. It’s possible that combining lessons learned from years of studying fibromyalgia might one day inform new treatments for chronic pain and opioid use disorder. More research is needed. This is just the beginning,” said Clauw.

Additional authors include Parker Entrup; Megan Deaner; Craig Bryan; Steven E Harte; Chelsea M Kaplan; and Kihn Luan Phan.

Funding/disclosures: Hall gave expert opinion about the opioid crisis to Lumanity and Emergent BioSolutions. Clauw has testified in state lawsuits against opioid manufacturers for their role in the opioid overdose crisis. The remaining authors report no relevant conflicts of interest.

The Care Innovation and Community Improvement Plan, a program of the Ohio Department of Medicaid, provided funding.

Paper cited: “Fibromyalgia predicts increased odds of pain-related addiction exacerbation among individuals with pain and opioid use disorder,” PAIN. DOI: 10.1097/j.pain.0000000000002878


More Articles About:

Pain management Acute Pain chronic pain Preventative health and wellness Pharmacy
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Dark blue kid's bedroom at night.
Health Lab

School night bedtime tips every parent should know

U-M pediatrician warns that if kids aren’t getting enough sleep, learning is difficult and other problems may arise. Learn how many hours of sleep kids need.
Portrait of Thomas Macek. He's wearing a navy blazer and light blue button-down shirt.
Philanthropy News

College of Pharmacy alum advances U-M Medical School addiction research

Grateful for support that help launched his career in pharmacology research and drug development, Tom Macek, Ph.D., has made a gift to the University of Michigan Medical School to advance addiction research.
e-bike handles on road close up
Health Lab

E-bikes are faster than ever. Are families prepared for the risks?

As e-bikes and e-scooters grow in popularity, Michigan Medicine experts are warning families that many riders and parents may not fully understand the speeds these devices can reach or the injuries that can follow when things go wrong.
bathroom toliets pattern and orange background
Health Lab

Got cyclosporiasis? How to take care of yourself and others

As the Cyclospora parasite outbreak sickens many, a primary care doctor’s top tips to get through it.
word statin in capital letters blue and pill out of silver case
Health Lab

More than half of U.S. adults now qualify for statins under new guidelines

Cholesterol-lowering medicines called statins can reduce heart attack and stroke risk decades later; a study finds millions more people should be taking them.
person holding scale with scrubs on and stethoscope
Health Lab

7 things to know about Medicare’s new GLP-1 coverage

Medicare coverage of GLP-1 drugs for weight loss including Wegovy and Zepbound has begun but has limits.